NDC 64239-300

HEMADY

Dexamethasone

HEMADY is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Dexcel Pharma Technologies Ltd.. The primary component is Dexamethasone.

Product ID64239-300_7cf0cc84-5689-4343-b3ef-92617406ee20
NDC64239-300
Product TypeHuman Prescription Drug
Proprietary NameHEMADY
Generic NameDexamethasone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-03-31
Marketing CategoryNDA /
Application NumberNDA211379
Labeler NameDexcel Pharma Technologies Ltd.
Substance NameDEXAMETHASONE
Active Ingredient Strength20 mg/1
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC SPL Data Element Entries

NDC 64239-300-10 [64239030010]

HEMADY TABLET
Marketing CategoryNDA
Application NumberNDA211379
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-03-31
Marketing End Date2020-03-31

Drug Details

NDC Crossover Matching brand name "HEMADY" or generic name "Dexamethasone"

NDCBrand NameGeneric Name
72893-015HemadyHemady
0054-3177DexamethasoneDexamethasone
0054-4179DexamethasoneDexamethasone
0054-4180DexamethasoneDexamethasone
0054-4181DexamethasoneDexamethasone
0054-4182DexamethasoneDexamethasone
0054-4183DexamethasoneDexamethasone
0054-4184DexamethasoneDexamethasone
0054-4186DexamethasoneDexamethasone
0054-8174DexamethasoneDexamethasone
0023-3348OZURDEXdexamethasone

Trademark Results [HEMADY]

Mark Image

Registration | Serial
Company
Trademark
Application Date
HEMADY
HEMADY
88519605 not registered Live/Pending
Dexcel Pharma Technologies Ltd.
2019-07-17
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.